Breaking News Instant updates and real-time market news.

Two Harbors management to meet with JPMorgan

Meetings to be held in Boston on December 4 and in Arlington/Baltimore on December 5 hosted by JPMorgan.

05

Dec

TWOTwo Harbors

$16.14

0.08 (0.50%)

07/05/17

FBCO

07/05/17INITIATIONTarget $10.5FBCOOutperform

Two Harbors reinstated with an Outperform at Credit Suisse

Credit Suisse analyst Douglas Harter reinstated coverage of Two Harbors (TWO) with an Outperform rating and a $10.50 price target following the completion of the Granite Point Mortgage (GPMT) IPO. While some of the valuation gap to peers has narrowed, the analyst continues to see Two Harbors as a "core holding" among the mREITs given the company's history of "strong" risk management, as well as "strong returns" as highlighted by the three dividend increases in the past three quarters.

07/05/17

07/05/17INITIATION

On The Fly: Top analyst initiations

Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Pandora (P) resumed with an Overweight at Morgan Stanley. 2. Two Harbors (TWO) reinstated with an Outperform at Credit Suisse. 3. Alcentra Capital (ABDC) initiated with a Buy at DA Davidson. 4. Alon USA Partners (ALDW) reinstated with an Equal Weight at Barclays. 5. Delek US (DK) and Delek Logistics (DKL) were reinstated with an Equal Weight at Barclays. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

11/10/17

RILY

11/10/17UPGRADERILYBuy

Two Harbors upgraded to Buy from Neutral at B. Riley FBR

B. Riley FBR analyst Jessica Levi-Ribner upgraded Two Harbors to Buy.

11/10/17

RILY

11/10/17UPGRADETarget $16.5RILYBuy

Two Harbors upgraded to Buy on attractive valuation at B. Riley FBR

B. Riley FBR analyst Jessica Levi-Ribner upgraded Two Harbors Investment Corp. to Buy from Neutral while lowering her price target for the shares to $16.50 from $20. The analyst views the Q3 result as solid following the recent spin-out of Granite Point Mortgage Trust. The shares are as attractively valued, currently trading at a near-7% discount to book value, Levi-Ribner tells investors in a post-earnings research note.

AT&T Mobility has reached a tentative agreement with the Communications Workers of America in Mobility Orange contract negotiations. The four-year agreement, which will be submitted to the union's membership for a ratification vote in coming days, covers about 20,000 employees in 36 states and the District of Columbia - AT&T's Mobility Orange unit, which encompasses CWA Districts 1, 2-13, 4, 7 and 9.

Pfizer announced that the United States FDA has approved IXIFI, a chimeric human-murine monoclonal antibody against tumor necrosis factor, as a biosimilar to Remicade for all eligible indications of the reference product. The FDA has approved IXIFI as a treatment for patients with rheumatoid arthritis, Crohn's disease, pediatric Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

Western Alliance Bancorporation announced that during the first quarter of 2018 Robert Sarver will transition from Chairman and CEO to Executive Chairman. In conjunction with Sarver's change in role, Ken Vecchione will be promoted to Chief Executive Officer, Dale Gibbons to Vice Chairman and Chief Financial Officer, and James Haught to President and Chief Operating Officer, all effective April 1, 2018.

Aqua America announced that President and CEO Christopher H. Franklin has been elected chairman of the board, effective Jan. 1, 2018. Franklin became CEO in July 2015 and has served on the board of directors since October 2015. He succeeds Nicholas DeBenedictis, former CEO, who will continue to serve on the board as chairman emeritus.